A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies

NCT00006072 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Peripheral Neuropathy

Interventions

DRUG: Rituxan

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]